No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs527251071 |
chr11:67764327-67764328 |
Enhancers Active TSS Flanking Active TSS Genic enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer
|
TF binding regionCpG islandChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs552190505 |
chr11:67764408-67764409 |
Enhancers Active TSS Flanking Active TSS Genic enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs570652487 |
chr11:67764429-67764430 |
Enhancers Active TSS Flanking Active TSS Genic enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs114060891 |
chr11:67764447-67764448 |
Enhancers Active TSS Flanking Active TSS Genic enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs114589544 |
chr11:67764464-67764465 |
Enhancers Active TSS Flanking Active TSS Genic enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs61887536 |
chr11:67764517-67764518 |
Enhancers Active TSS Flanking Active TSS Genic enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs556375296 |
chr11:67764519-67764520 |
Enhancers Active TSS Flanking Active TSS Genic enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs568224747 |
chr11:67764529-67764530 |
Enhancers Active TSS Flanking Active TSS Genic enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs535666095 |
chr11:67764564-67764565 |
Enhancers Active TSS Flanking Active TSS Genic enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs148327744 |
chr11:67764635-67764636 |
Enhancers Flanking Active TSS Genic enhancers Active TSS Weak transcription Strong transcription
|
TF binding regionChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs572544777 |
chr11:67764662-67764663 |
Enhancers Flanking Active TSS Genic enhancers Active TSS Weak transcription Strong transcription
|
TF binding regionCpG islandChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs2428815 |
chr11:67764663-67764664 |
Enhancers Flanking Active TSS Genic enhancers Active TSS Weak transcription Strong transcription
|
TF binding regionCpG islandChromatin interactive region
|
6 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
13 |
rs55758147 |
chr11:67764681-67764682 |
Enhancers Flanking Active TSS Genic enhancers Active TSS Weak transcription Strong transcription
|
TF binding regionCpG islandChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs34985263 |
chr11:67764695-67764696 |
Enhancers Flanking Active TSS Genic enhancers Active TSS Weak transcription Strong transcription
|
TF binding regionCpG islandChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs558163630 |
chr11:67764697-67764698 |
Enhancers Flanking Active TSS Genic enhancers Active TSS Weak transcription Strong transcription
|
TF binding regionCpG islandChromatin interactive region
|
6 gene(s)
|
Overlapped CNVs
|
n/a
|